Clinical Trial Update: A Pilot of Methylphenidate in Mild Cognitive Impairment and Dementia Participants. [Phase 4]

View source ↗

Summary

A Phase 4 pilot study evaluated methylphenidate in participants with Alzheimer dementia; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Alzheimer Dementia | Phase 4 | Status: COMPLETED | Results posted: 2023-06-02